Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Inv. presentation
Quarterly results
Appointed director

APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Beryl Capital Management LLC reports a 0% stake in Applied Genetic Technologies Corporation
12/12/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
12/08/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
12/07/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/07/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/07/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/01/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/01/2022 4 Robinson James A. Jr. (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 25,000 options to buy @ $2.17, valued at $54.3k
12/01/2022 4 VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 16,000 options to buy @ $15.13, valued at $242.1k
Disposed/sold 8,000 options to buy @ $7.75, valued at $62k
Disposed/sold 10,000 options to buy @ $4.25, valued at $42.5k
Disposed/sold 10,000 options to buy @ $6.9, valued at $69k
Disposed/sold 10,000 options to buy @ $3.02, valued at $30.2k
Disposed/sold 12,000 options to buy @ $4.72, valued at $56.6k
Disposed/sold 14,000 options to buy @ $2.17, valued at $30.4k
12/01/2022 4 Rosen James (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 1,000 shares @ $0
Disposed/sold 9,375 options to buy @ $12, valued at $112.5k
Disposed/sold 4,688 options to buy @ $20.83, valued at $97.7k
Disposed/sold 6,200 options to buy @ $16.06, valued at $99.6k
Disposed/sold 8,000 options to buy @ $7.75, valued at $62k
Disposed/sold 10,000 options to buy @ $4.25, valued at $42.5k
Disposed/sold 10,000 options to buy @ $6.9, valued at $69k
Disposed/sold 10,000 options to buy @ $3.02, valued at $30.2k
Disposed/sold 12,000 options to buy @ $4.72, valued at $56.6k
Disposed/sold 14,000 options to buy @ $2.17, valued at $30.4k
12/01/2022 4 Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 8,500 shares @ $0
Disposed/sold 25,000 options to buy @ $4.4, valued at $110k
Disposed/sold 10,000 options to buy @ $6.9, valued at $69k
Disposed/sold 10,000 options to buy @ $3.02, valued at $30.2k
Disposed/sold 12,000 options to buy @ $4.72, valued at $56.6k
Disposed/sold 14,000 options to buy @ $2.17, valued at $30.4k
12/01/2022 4 HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 25,672 shares @ $0
Unknown transaction of 1,800 shares @ $0
Disposed/sold 9,375 options to buy @ $12, valued at $112.5k
Disposed/sold 4,688 options to buy @ $20.83, valued at $97.7k
Disposed/sold 6,200 options to buy @ $16.06, valued at $99.6k
Disposed/sold 8,000 options to buy @ $7.75, valued at $62k
Disposed/sold 10,000 options to buy @ $4.25, valued at $42.5k
Disposed/sold 10,000 options to buy @ $6.9, valued at $69k
Disposed/sold 10,000 options to buy @ $3.02, valued at $30.2k
Disposed/sold 12,000 options to buy @ $4.72, valued at $56.6k
Disposed/sold 14,000 options to buy @ $2.17, valued at $30.4k
12/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/01/2022 4 Hashad Yehia (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 25,000 options to buy @ $3.42, valued at $85.5k
Disposed/sold 14,000 options to buy @ $2.17, valued at $30.4k
12/01/2022 4 Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 34,246 shares @ $0
Disposed/sold 14,285 options to buy @ $4.9, valued at $70k
Disposed/sold 9,375 options to buy @ $12, valued at $112.5k
Disposed/sold 4,688 options to buy @ $20.83, valued at $97.7k
Disposed/sold 6,200 options to buy @ $16.06, valued at $99.6k
Disposed/sold 8,000 options to buy @ $7.75, valued at $62k
Disposed/sold 10,000 options to buy @ $4.25, valued at $42.5k
Disposed/sold 10,000 options to buy @ $6.9, valued at $69k
Disposed/sold 10,000 options to buy @ $3.02, valued at $30.2k
Disposed/sold 12,000 options to buy @ $4.72, valued at $56.6k
Disposed/sold 14,000 options to buy @ $2.17, valued at $30.4k
12/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/01/2022 4 Reynolds Gerald Anthony (Chief Accounting Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 8,506 shares @ $0
Disposed/sold 42,500 shares @ $0
Disposed/sold 50,000 options to buy @ $3.28, valued at $164k
Disposed/sold 30,000 options to buy @ $5.5, valued at $165k
Disposed/sold 34,500 options to buy @ $3.7, valued at $127.7k
12/01/2022 4 Scaria Abraham (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 220,000 options to buy @ $1.98, valued at $435.6k
Disposed/sold 124,500 options to buy @ $0.4, valued at $49.8k
12/01/2022 4 Potter Stephen W (Chief Business Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 47,133 shares @ $0
Disposed/sold 8,750 shares @ $0
Disposed/sold 131,049 options to buy @ $24.62, valued at $3.2M
Disposed/sold 51,000 options to buy @ $18.48, valued at $942.5k
Disposed/sold 50,000 options to buy @ $15.57, valued at $778.5k
Disposed/sold 50,000 options to buy @ $4.9, valued at $245k
Disposed/sold 85,000 options to buy @ $4.25, valued at $361.3k
Disposed/sold 52,000 options to buy @ $3, valued at $156k
Disposed/sold 50,000 options to buy @ $5.5, valued at $275k
Disposed/sold 60,000 options to buy @ $3.74, valued at $224.4k
Disposed/sold 133,100 options to buy @ $0.4, valued at $53.2k
12/01/2022 4 DOyley-Gay Hope (General Counsel) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 180,000 options to buy @ $2.02, valued at $363.6k
Disposed/sold 147,900 options to buy @ $0.4, valued at $59.2k
12/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/01/2022 4 Schneider Susan (Chief Medical Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 180,000 options to buy @ $2.76, valued at $496.8k
Disposed/sold 142,300 options to buy @ $0.4, valued at $56.9k
12/01/2022 4 Lieber Jonathan I (CFO) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Disposed/sold 202,000 options to buy @ $3.3, valued at $666.6k
Disposed/sold 154,700 options to buy @ $0.4, valued at $61.9k
12/01/2022 4 Washer Susan B. (President and CEO) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Unknown transaction of 143,021 shares @ $0
Disposed/sold 140,000 options to buy @ $4.9, valued at $686k
Disposed/sold 99,156 options to buy @ $14.08, valued at $1.4M
Disposed/sold 55,780 options to buy @ $16, valued at $892.5k
Disposed/sold 80,000 options to buy @ $18.48, valued at $1.5M
Disposed/sold 80,000 options to buy @ $15.57, valued at $1.2M
Disposed/sold 100,000 options to buy @ $4.9, valued at $490k
Disposed/sold 100,000 options to buy @ $4.25, valued at $425k
Disposed/sold 100,000 options to buy @ $3, valued at $300k
Disposed/sold 169,000 options to buy @ $5.5, valued at $929.5k
Disposed/sold 275,000 options to buy @ $3.74, valued at $1M
12/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/01/2022 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Sixth Amended and Restated Certificate of Incorporation of the Company",
"Second Amended and Restated Bylaws of the Company"
12/01/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
12/01/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/29/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation"
11/29/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy